Angelicain

CAS No. 49624-66-0

Angelicain( Norcimifugin )

Catalog No. M24454 CAS No. 49624-66-0

Angelicain is a constituent of Cimicifuga foetida with anti-inflammatory activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 90 In Stock
5MG 93 In Stock
10MG 162 In Stock
25MG 273 In Stock
50MG 384 In Stock
100MG 533 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Angelicain
  • Note
    Research use only, not for human use.
  • Brief Description
    Angelicain is a constituent of Cimicifuga foetida with anti-inflammatory activity.
  • Description
    Angelicain is a constituent of Cimicifuga foetida with anti-inflammatory activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Norcimifugin
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    49624-66-0
  • Formula Weight
    292.3
  • Molecular Formula
    C15H16O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (342.14 mM)
  • SMILES
    CC(C)(C(C1)Oc(cc2OC(CO)=C3)c1c(O)c2C3=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lu L, et al. Studies on the constituents of Cimicifuga foetida collected in Guizhou Province and their cytotoxic activities. Chem Pharm Bull (Tokyo). 2012;60(5):571-7.
molnova catalog
related products
  • Aloin B

    The extract of A. vera and its active ingredient aloin cause melanin aggregation leading to skin lightening via alpha adrenergic receptor stimulation.

  • CID1375606

    CID 1375606 is a surrogate agonist of orphan G protein-coupled receptor?GPR27. characterized by a high level of conservation among vertebrates and a predominant expression in the central nervous system.

  • [Lys3]–Bombesin

    [Lys3]-Bombesin is a biological active peptide. (PET (Positron Emission Tomography) imaging of [Lys3]-bombesin is able to detect gastrin-releasing peptide receptor (GRPR) positive prostate cancer. An immunoconjugate of [Lys3]-bombesin and corresponding monoclonal antibody can specifically induce (CD64)-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma.)